Meihua International Medical Technologies Co., Ltd. MHUAF

7.00 0.00 0.00% as of 24 Sep
Market cap
$4.3M
P/E
—
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
P/S ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
P/Operating CF
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
EV/Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
EV/Operating CF
(0.86) (0.69) 0.72 0.00 0.00 0.00 0.00 —
EV/FCF
(0.88) (0.79) 0.51 0.00 0.00 0.00 0.00 —
Quick Ratio
7.37 4.85 4.64 4.87 3.25 3.08 3.80 —
Current Ratio
8.42 5.26 5.27 5.60 3.34 3.17 3.88 —
Net Debt/EBITDA
(0.70) (0.63) (0.63) (1.75) (0.11) (0.17) (0.68) —
Debt/Assets
4.34% 4.27% 4.26% 4.17% 3.78% 3.03% 3.53% 0.00%
Debt/Equity
0.05 0.05 0.05 0.05 0.05 0.04 0.04 —
Asset Turnover
0.31 0.54 0.58 0.69 0.86 0.99 2.18 —
Operating CF/Net income
0.08 1.35 0.20 (1.47) 0.00 0.28 0.60 —
Capex/Depreciation
(0.03) (0.23) (9.21) (4.75) (1.34) (30.75) 0.00 —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
ROE
3.90% 7.09% 8.14% 5.07% 21.77% 26.38% 21.37% —
ROA
3.45% 6.06% 6.93% 4.16% 17.25% 21.25% 42.16% —
ROIC
2.83% 5.98% 6.68% 5.68% 15.66% 18.16% 0.00% —
Return on Tangible Assets
4.74% 8.74% 10.02% 5.21% 27.69% 35.69% 36.37% —
Average Days of Receivables
705.08 433.13 373.95 321.51 303.41 239.98 162.33 —
Research and Development Expense of Revenue
3.86% 3.57% 2.84% 2.87% 2.62% 2.80% 4.03% —
Selling, General and Administrative Expense of Revenue
12.03% 14.88% 14.25% 18.94% 10.40% 12.58% 11.71% —
Intangible Assets out of Total Assets
0.00 0.00 0.02 0.00 0.00 0.01 0.01 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Graham Net Nets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Revenue per Share
164.34 354.07 405.59 441.46 520.19 445.31 3.30 —
Operating CF per Share
1.52 53.48 9.51 (39.14) (0.27) 26.63 0.39 —
Capex per Share
(0.04) (0.49) (18.12) (11.43) (4.17) (80.47) 0.00 —
Free Cash Flow per Share
1.47 52.99 (8.62) (50.57) (4.44) (53.84) 0.39 —
Cash per Share
40.30 63.17 70.71 114.21 40.75 35.94 0.66 —
Shareholders Equity per Share
502.48 580.84 613.36 592.39 538.84 423.68 2.47 —
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Book value per Share
502.48 580.84 613.36 592.39 538.84 423.68 2.47 —
Free Cash Flow
0.55 14.50 (2.06) (11.84) (0.89) (10.77) 9.31 —
Working Capital
135.33 116.17 107.16 111.15 68.19 46.25 39.03 —
Capital Expenditures
(0.02) (0.13) (4.34) (2.68) (0.83) (16.09) (8.95) —
Net Current Asset Value
135.33 116.17 107.16 110.42 68.19 46.25 39.03 —
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Capex to Sales
0.00 0.00 0.04 0.03 0.01 0.18 0.00 —
Net Profit Margin
10.98% 11.19% 11.97% 6.04% 20.14% 21.38% 19.38% —
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Other line items
Depreciation/Fixed assets
0.07 0.07 0.05 0.06 0.08 0.07 0.15 —
Cash ROIC
(3.35%) 3.66% (3.83%) (10.41%) (6.22%) (1.87%) 7.55% —
Accounts Receivable Turnover
0.53 0.90 1.02 1.16 1.43 1.90 1.69 —
Accounts Payable Turnover
3.57 4.06 4.00 3.52 3.51 4.15 3.82 —
Inventory Turnover
27.38 42.03 46.66 54.98 49.84 44.15 40.58 —
Average Days of Payables
72.09 88.80 90.38 90.04 119.22 109.98 71.62 —
Days of Inventory on Hand
14.59 8.09 9.24 6.28 7.11 9.33 7.84 —
Average Receivables
117.18 107.24 95.26 88.76 72.52 46.98 46.98 —
Average Payables
11.95 15.65 15.96 18.54 18.31 12.50 12.50 —
Average Inventory
1.56 1.51 1.37 1.19 1.29 1.18 1.18 —
Average Assets
196.71 179.08 167.75 150.22 121.45 89.63 36.60 —
Average Common Equity
173.95 152.91 142.76 123.22 96.25 72.20 72.20 —

Fold the line items

Columns are period end dates